These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of left main coronary trifurcation lesions with the paclitaxel drug-eluting stent: mid-term outcomes from a tertiary medical center. Shammas NW, Shammas GA, Jerin M, Parikh A, Coin K, Dippel E, Sharis P, Robken J. J Invasive Cardiol; 2009 Jul; 21(7):321-5. PubMed ID: 19571341 [Abstract] [Full Text] [Related]
4. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz KL, Dirschinger J, Schömig A, LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators. J Am Coll Cardiol; 2009 May 12; 53(19):1760-8. PubMed ID: 19422982 [Abstract] [Full Text] [Related]
5. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry. Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ. J Am Coll Cardiol; 2009 Aug 25; 54(9):853-9. PubMed ID: 19695467 [Abstract] [Full Text] [Related]
6. Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Gonzalo N, Cook S, Marra S, Moretti C, De Servi S, Palacios IF, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW. Int J Cardiol; 2009 Sep 11; 137(1):16-21. PubMed ID: 18687481 [Abstract] [Full Text] [Related]
7. High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease. Migliorini A, Valenti R, Marcucci R, Parodi G, Giuliani G, Buonamici P, Cerisano G, Carrabba N, Gensini GF, Abbate R, Antoniucci D. Circulation; 2009 Dec 01; 120(22):2214-21. PubMed ID: 19917884 [Abstract] [Full Text] [Related]
9. Percutaneous coronary intervention with stenting of left main coronary artery with drug-eluting stent in the setting of acute ST elevation myocardial infarction. Tan CH, Hong MK, Lee CW, Kim YH, Lee CH, Park SW, Park SJ. Int J Cardiol; 2008 May 23; 126(2):224-8. PubMed ID: 17493695 [Abstract] [Full Text] [Related]
11. One-year outcomes with the Taxus Liberté stent in the real world: the Taxus Olympia registry (phase I). Ahmed WH, Zambahari R, Al-Rashdan I, Al Naeemi A, Saeed FA, Mascioli S. J Interv Cardiol; 2008 Dec 23; 21(6):512-8. PubMed ID: 18973513 [Abstract] [Full Text] [Related]
15. Coronary artery stenting in patients treated by clopidogrel without aspirin. Rott D, Leibowitz D, Amit G, Zahger D, Weiss AT. Int J Cardiol; 2009 Apr 03; 133(2):279-81. PubMed ID: 18178268 [Abstract] [Full Text] [Related]
16. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. Kim YH, Dangas GD, Solinas E, Aoki J, Parise H, Kimura M, Franklin-Bond T, Dasgupta NK, Kirtane AJ, Moussa I, Lansky AJ, Collins M, Stone GW, Leon MB, Moses JW, Mehran R. Am J Cardiol; 2008 Mar 15; 101(6):801-6. PubMed ID: 18328844 [Abstract] [Full Text] [Related]
18. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, Dauerman HL, Ryan TJ, Kiernan FJ, Cutlip DE, Ho KK, Gibson CM, Murphy SA, Cohen DJ. Am Heart J; 2008 Apr 15; 155(4):654-60. PubMed ID: 18371472 [Abstract] [Full Text] [Related]